(S (S (S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ controls) (NP (NP (NN expression)) (PP (IN of) (NP (NN inhibitor) (NN I) (NN kappa) (NN B) (NN alpha)))))) (: :) (NP (NP (NN evidence)) (PP (IN for) (NP (DT an) (JJ inducible) (JJ autoregulatory) (NN pathway))))) (. .))
(S (NP-SBJ (DT The) (JJ eukaryotic) (NN transcription) (NN factor) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-)))) (VP (VBZ participates) (PP (IN in) (NP (NP (JJ many) (NNS parts)) (PP (IN of) (NP (NP (DT the) (JJ genetic) (NN program)) (VP (VBG mediating) (NP (NN T) (NN lymphocyte) (NP-COOD (NP (NN activation)) (CC and) (NP (NN growth)))))))))) (. .))
(S (NP-SBJ (NP (JJ Nuclear) (NN expression)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBZ occurs) (PP-TMP (IN after) (NP (NP (PRP$ its) (VBN induced) (NN dissociation)) (PP (IN from) (NP (PRP$ its) (JJ cytoplasmic) (NN inhibitor) (NN I) (NN kappa) (NN B) (NN alpha)))))) (. .))
(S (NP-SBJ-48 (NP (NP-COOD (NP (NN Phorbol) (NN ester)) (CC and) (NP (NN tumor) (NN necrosis) (NN factor-alpha))) (NN induction)) (PP (IN of) (NP (JJ nuclear) (NN NF-kappa) (NN B)))) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-48)) (PP (IN with) (NP-COOD (CC both) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (VBN performed) (NN I) (NN kappa) (NN B) (NN alpha)))) (CC and) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha) (NN gene) (NN expression)))))))) (. .))
(S (NP-SBJ (NN Transfection) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-49 (DT the) (NN I) (NN kappa) (NN B) (NN alpha) (NN gene)) (VP (VBZ is) (ADVP (RB specifically)) (VP (VBN induced) (NP (-NONE- *-49)) (PP (IN by) (NP-LGS (NP (DT the) (JJ 65-kilodalton) (VBG transactivating) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))))))) (. .))
(S (NP-SBJ (NP (NN Association)) (PP (IN of) (NP (DT the) (ADJP (RB newly) (VBN synthesized)) (NN I) (NN kappa) (NN B) (NN alpha))) (PP (IN with) (NP (NN p65)))) (VP-COOD (VP (VBZ restores) (NP (NP (JJ intracellular) (NN inhibition)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN DNA) (NN binding) (NN activity))))) (CC and) (VP (VBZ prolongs) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (DT this) (JJ labile) (NN inhibitor)))))) (. .))
(S (ADVP (RB Together)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ controls) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (PP (IN by) (NNS means) (IN of) (NP (DT an) (JJ inducible) (JJ autoregulatory) (NN pathway))))))) (. .))
